Ex-Genzyme official to lead testing firm
On-Q-ity aims to help doctors decide on cancer treatment
Former Genzyme Corp. senior executive Mara Aspinall has taken the helm of a new cancer diagnostics business, On-Q-ity Inc. (Full article: 462 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
